These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8124728)

  • 1. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.
    Cleland JL; Powell MF; Shire SJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(4):307-77. PubMed ID: 8124728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH control of nucleophilic/electrophilic oxidation.
    Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
    Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating shelf-life of drugs in solution.
    Newton DW; Miller KW
    Am J Hosp Pharm; 1987 Jul; 44(7):1633-40. PubMed ID: 3631095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput screening of protein formulation stability: practical considerations.
    Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2007 Feb; 65(2):131-48. PubMed ID: 17107777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and manufacturability of biologics.
    Shire SJ
    Curr Opin Biotechnol; 2009 Dec; 20(6):708-14. PubMed ID: 19880308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS; Beauvais RM; Dong A; Carpenter JF
    Arch Biochem Biophys; 1996 Jul; 331(2):249-58. PubMed ID: 8660705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on stability of protein drug products during formulation, fill and finish operations.
    Rathore N; Rajan RS
    Biotechnol Prog; 2008; 24(3):504-14. PubMed ID: 18484778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the stability of biological standards and products.
    Kirkwood TB
    Biometrics; 1977 Dec; 33(4):736-42. PubMed ID: 588659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sevoflurane formulation water content influences degradation by Lewis acids in vaporizers.
    Kharasch ED; Subbarao GN; Cromack KR; Stephens DA; Saltarelli MD
    Anesth Analg; 2009 Jun; 108(6):1796-802. PubMed ID: 19448204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.
    Brummitt RK; Nesta DP; Roberts CJ
    J Pharm Sci; 2011 Oct; 100(10):4234-43. PubMed ID: 21671226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of Tween 80 on protein stability.
    Wang W; Wang YJ; Wang DQ
    Int J Pharm; 2008 Jan; 347(1-2):31-8. PubMed ID: 17692480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Neulasta (pegfilgrastim).
    Piedmonte DM; Treuheit MJ
    Adv Drug Deliv Rev; 2008 Jan; 60(1):50-8. PubMed ID: 17822802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH dependent effect of glycosylation on protein stability.
    Wang W; Antonsen K; Wang YJ; Wang DQ
    Eur J Pharm Sci; 2008 Feb; 33(2):120-7. PubMed ID: 18162379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Storage stability of Anagrapha falcifera nucleopolyhedrovirus in spray-dried formulations.
    Tamez-Guerra P; McGuire MR; Behle RW; Shasha BS; Pingel RL
    J Invertebr Pathol; 2002 Jan; 79(1):7-16. PubMed ID: 12054782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.